Choosing apoptosis antibodies that report a decision rather than a protein: why a bcl-2 antibody and a bcl xl antibody measure a survival set point that only means something against a bim antibody and a bad antibody on the same blot, what an xiap antibody and a survivin antibody add about execution being blocked downstream, how a caspase 8 antibody or caspase-8 antibody, a caspase 9 antibody or caspase-9 antibody and a caspase 7 antibody separate the receptor route from the mitochondrial one, why a cleaved parp antibody is read differently from a parp antibody, a parp1 antibody, the parp 1 antibody spelling beside it or a parp2 antibody, where an annexin v antibody and a dr5 antibody sit on the surface rather than in the lysate, what a fadd antibody reports about complex assembly, how an mdm2 antibody changes what a p53 result means, and what the apoptosis antibodies sold as a bundle can and cannot settle

Assembling the panel

1. Measure the balance, not one side of it. A survival protein rising means nothing without knowing what the sensitisers did. Blot at least one from each side on the same membrane, and report the ratio rather than the individual intensities.
2. Use cleaved substrate as the execution readout. A cleaved substrate is direct evidence that the machinery ran. Total substrate is a loading reference. Confusing the two is the most common misreading in this area, and reagents for both are sold under similar names.
3. Separate the two initiating routes. Receptor initiated and mitochondrial routes converge on the same executioners, so an executioner readout cannot tell you which fired. Blotting the two initiators, or blocking one, is what distinguishes them.
4. Collect the cells that detached. Dying cells lift off, and a lysate made from the adherent layer alone systematically under reports death. Collect the medium, spin it and add those cells back before lysis.
5. Confirm with an orthogonal readout. A surface stain, a fluorogenic activity assay or a viability count alongside the blot turns a suggestive band into a result. Two methods agreeing is what makes this class of experiment credible.

Death is a ratio, not a band

The decision to die is made by the balance between proteins that hold the mitochondrial membrane intact and proteins that permeabilise it. That is why a single measurement is uninformative and why panels in this area are bought as sets rather than as individual reagents.

Design the blot as a panel from the start: two survival proteins, two sensitisers, one initiator from each route and one cleaved substrate. It fits on one membrane with fluorescent multiplexing and answers far more than a series of single blots.

Timing decides what you see

Cleaved products appear and are then degraded along with the cell. A single timepoint chosen for convenience routinely lands after the peak, which produces a negative result from a positive experiment.

Run one time course per cell type and treatment, choose the timepoint from it, and use that timepoint consistently. It is one experiment that makes everything after it interpretable.

Common questions

Why is my caspase blot negative when the cells clearly died?

Frequently because the dying cells detached and were washed away before lysis, or because the timepoint sat after the peak. Collect the supernatant cells and run a time course before concluding the pathway was not involved.

Total or cleaved reagents?

Cleaved for the question of whether death occurred, total as the loading reference. Buying only the total reagent is the commonest way to end up with a blot that cannot answer the question asked of it.

Is a survival protein level meaningful on its own?

Rarely. It sets a threshold that only means something relative to the sensitisers present. Report both, and treat any single value as descriptive rather than mechanistic.

Browse by service class

• Compare Gene synthesis on advertised prices